LindaRN_retired said:The version of this that has an answer is narrower than the version being asked.
Agreed, though "tolerable" needs defining. A dose you tolerate by eating almost nothing is not tolerated, it is being paid for somewhere else — usually in lean mass, sometimes in adherence three months later.
RickReta_CO said:The mechanism that matters here is not stomach emptying, it is central.
Thank you — that is the clearest version of this I have read, and I have read a lot of them. I will report back once I have actually tried it.
LindaRN_retired said:The version of this that has an answer is narrower than the version being asked.
Pushing back on LindaRN_retired here. The trial means are being read too generously in this thread. STEP populations were selected, supported, and titrated by protocol, and the real-world curves are consistently a few points worse. That difference is not noise, it is what happens when you remove the study infrastructure.
If somebody has the primary source to hand I would rather cite it than paraphrase it.
Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.
View ResultsOne concrete data point for the thread. Give anything pharmacological four weeks before you judge it, and give anything measured weekly a four-point rolling average before you call it a trend.
Happy to go further on any of that.
